The therapy works with two injections per year, according to the initial test get the desired results in a few weeks. The molecule, the inclisiran, is an inhibitor of a gene called PCSK9 , the goal of the other drugs developed by different companies, and allows the liver to absorb more cholesterol 'bad'. The first phase of the test, which will be limited to England, and will involve subjects who have not had a cardiovascular event serious, but are considered high risk, but if the outcome is judged as positive, the use is to be extended, including at least 300 thousand people. "This partnership - said the minister of Health british Matt Hancock, has the potential to save 30 thousand lives in the next ten years, and is proof that the Uk continues to be the leading destination in the world for the assistance of more advanced".
"The Republic will fight always in defense of the freedom of information, to its readers and to all those who have at heart the principles of democracy and civil coexistence"Carlo Verdelli SUBSCRIBERS TO REPUBLIC © Reproduction reserved Today on a Mission to Libya, so the Eu is preparing to send soldiers and ships In the libyan capital that changes the flag: “Tifavamo Italy, now we see the Russian tv” Haftar stops a step from the understanding, slide the truce of Putin, While the Eu fights the Tsar commands in Mare Nostrum In Erbil between the Italian soldiers stopped by the raid of Tehran: “Now Isis can return”